Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma

Cancer Research

Volumn 57, Issue 20, 1997, Pages 4557-4563

  Micallef, Mark J ^a   Tanimoto, Tadao ^a   Kohno, Keizo ^a   Ikeda, Masao ^a   Kurimoto, Masashi ^a  

^a HAYASHIBARA BIOCHEMICAL LABORATORIES INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER TRANSPLANTATION; CELL PROTECTION; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; DRUG EFFECT; IMMUNE RESPONSE; IMMUNOCOMPETENCE; IMMUNOTHERAPY; KILLER CELL; LYMPHOCYTE COUNT; MOUSE; NONHUMAN; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; SARCOMA; SPLEEN CELL;

ANIMALS; ANTICARCINOGENIC AGENTS; CELLS, CULTURED; CONCANAVALIN A; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-18; INTERLEUKIN-2; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; SARCOMA, EXPERIMENTAL; SPLEEN; T-LYMPHOCYTES, CYTOTOXIC; TIME FACTORS; TRANSPLANTATION, ISOGENEIC;

EID: 0030766468     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Fu, Y-X., Watson, G. A., Kasahara, M., and Lopez, D. M. The role of tumor-derived cytokines on the immune system of mice bearing a mammary adenocarcinoma. I. induction of regulatory macrophages in normal mice by the in vivo administration of rGM-CSF. J. Immunol., 146: 783-789, 1991.
2. + T cells. J. Immunol., 149: 949-956, 1992.
3. Xu, Z-Y., Hosokawa, M., Morikawa, K., Hatakeyama, M., and Kobayashi, H. Overcoming suppression of antitumor immune reactivity in tumor-bearing rats by treatment with bleomycin. Cancer Res., 48: 6658-6663, 1988.
4. 3 plus γ-interferon blocks lung tumor production of granulocyte macrophage colony-stimulating factor and induction of immunosuppressor cells. Cancer Res., 53: 6006-6010, 1993.
5. Micallef, M. Immunoregulatory cytokine production by tumor-bearing rat spleen cells and its modulation by bleomycin. Anticancer Drugs. 4: 213-222, 1993.
6. Okamura, H., Tsutsui, H., Komatsu, T., Yutsudo, M., Hakura, A., Tanimoto, T., Torigoe, K., Okura, T., Nukada, Y., Hattori, K., Akita, K., Namba, M., Tanabe, F., Konishi, K., Fukuda, S., and Kurimoto, M. Cloning of a new cytokine that induces IFN-γ production by T cells. Nature (Lond.), 378: 88-91, 1995.
7. Ushio, S., Namba, M., Okura, T., Hattori, K., Nukada, Y., Akita, K., Tanabe, F., Konishi, K., Micallef, M., Fujii, M., Torigoe, K., Tanimoto, T., Fukuda, S., Ikeda, M., Okamura, H., and Kurimoto, M. Cloning of the cDNA for human IFN-γ-inducing factor, expression in Escherichia coli, and studies on the biologic activities of the protein. J. Immunol., 156: 4274-4279, 1996.
8. Kohno, K., Kataoka, J., Ohtsuki, T., Suemoto, Y., Okaraoto, I., Usui, M., Ikeda, M., and Kurimoto, M. IFN-γ-inducing factor (IGIF) is a costimulatory factor on the activation of Th 1 but not Th 2 cells and exerts its effect independently of IL-12. J. Immunol., 158: 1541-1550, 1997.
9. Micallef, M. J., Ohtsuki, T., Kohno, K., Tanabe, F., Ushio, S., Namba, M., Tanimoto, T., Torigoe, K., Fujii, M., Ikeda, M., Fukuda, S., and Kurimoto, M. Interferon-γ-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: synergism with interleukin-12 for interferon-γ production. Eur. J. Immunol., 26: 1647-1651, 1996.
10. Tsutsui, H., Nakanishi, K., Matsui, K., Higashino, K., Okamura, H., Miyazawa, Y., and Kaneda, K. IFN-γ-inducing factor up-regulates Fas ligand-mediated cytotoxic activity of murine natural killer cell clones. J. Immunol., 157: 3967-3973, 1996.
11. Micallef, M. J., Yoshida, K., Kawai, S., Hanaya, T., Kohno, K., Arai, Y., Tanimoto, T., Torigoe, K., Fujii, M., Ikeda, M., and Kurimoto, M. In vivo antitumor effects of murine interferon-γ-inducing factor/interleukin-18 in mice bearing syngeneic Meth A sarcoma malignant ascites. Cancer Immunol. Immunother., 43: 361-367, 1997.
12. Matzinger, P. The JAM test - a simple assay for DNA fragmentation and cell death. J. Immunol. Methods, 145: 185-192, 1991.
13. + suppressor effector T-cell clones from cytotoxic T-cell clones by cytokine production and CD45 isoforms. J. Immunol., 150: 2121-2128, 1993.
14. Nanda, N. K., Sercarz, E. E., Hsu, D-H., and Kronenberg, M. A unique pattern of lymphokine synthesis is a characteristic of certain antigen-specific suppressor T-cell clones. Int. Immunol., 6: 731-7373, 1994.
15. + T cells as novel interleukin-12-responsive killer T cell precursors. Jpn. J. Cancer Res., 87: 429-432, 1996.
16. Zheng, L. M., Ojcius, D. M., Garaud, F., Roth, C. Maxwell, E., Li, Z., Rong, H., Chen, J., Wang, X. Y., Catino, J. J., and King, I. Interleukin-10 inhibits tumor metastasis through an NK cell-dependent mechanism. J. Exp. Med., 184: 579-584, 1996.
17. Carson, G. E., Lindemann, M. J., Baiocchi, R., Linett, M., Tan, J. C., Chou, C-C., Narula, S., and Caligiuri, M. A. The functional characterization of interleukin-10 receptor expression on human natural killer cells. Blood, 85: 3577-3585, 1995.
18. Salazar-Onfray, F., Petersson, M., Franksson, L., Matsuda, M., Blankenstein, T., Karre, K., and Kiessling, R. IL-10 converts mouse lymphoma cells to a CTL-resistant, NK-sensitive phenotype with low but peptide-inducible MHC class I expression. J. Immunol., 154: 6291-6298, 1995.
19. Giovanelli, M., Musiani, P., Modesti, A., Dellabona, P., Castorati, G., Musso, T., and Forni, G. Local release of IL-10 by transfected mouse mammary adenocarcinoma cell does not suppress but enhances antitumor reaction and elicits a strong cytotoxic lymphocyte and antibody-dependent immune memory. J. Immunol., 155: 3112-3123, 1995.